Mom feels ‘helpless’ after UnitedHealthcare denies coverage for her son’s rehab after motorcycle accident
A South Carolina mother says she feels "helpless" after UnitedHealthcare allegedly denied coverage for specialist brain injury rehabilitation for her son, who was seriously hurt in a motorcycle crash. Trina Alvarez says the insurer's refusal, on the grounds that the treatment was "medically unnecessary," is delaying her son's transfer to a leading rehabilitation centre and reducing his chances of recovery, prompting her to accuse the company of prioritising profit over patient care.
Peyton Alvarez, 25, an airline mechanic, crashed into a tree while riding his motorcycle in Greenville on 28 April and suffered a severe brain injury that left him unconscious for six weeks, despite wearing protective gear. He has since shown small signs of improvement, including opening an eye and moving a hand, and his doctor recommended he be moved to the Shepherd Center in Atlanta, a specialist facility where around 85% of admitted patients see improvement. However, UnitedHealthcare rejected both the initial claim and a subsequent appeal, a decision Trina Alvarez says has caused huge distress; she also referenced the wider public anger the insurer has faced since the killing of its former chief executive.
- Mother says UnitedHealthcare denied son's brain injury rehab as "unnecessary"
- Son, 25, was badly hurt in a South Carolina motorcycle crash in April
- Top rehab centre accepted him, but insurer rejected claim and appeal
New here? Start with this
Trina Alvarez, from South Carolina, says UnitedHealthcare has refused to pay for specialist brain injury rehabilitation for her son Peyton, a 25-year-old airline mechanic. He was seriously injured in a motorcycle crash near Greenville in late April, spending six weeks unconscious, and his doctor wants him moved to the Shepherd Center, a specialist rehab facility in Atlanta known for strong recovery outcomes.
UnitedHealthcare is one of the largest health insurers in the United States, and disputes over which treatments it will cover, and on what grounds, are common and closely watched. In this case the company has twice refused the claim, saying the treatment is "medically unnecessary," a decision Trina Alvarez is contesting on her son's behalf.
The case has drawn attention partly because it touches on the broader debate in America over health insurers' power to approve or deny costly treatments, an issue that has been under heightened public scrutiny following the killing of UnitedHealthcare's former chief executive.
Both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Those who defend the insurer's approach would argue that medical necessity reviews exist precisely to ensure that costly, specialised treatments are matched to a patient's demonstrated clinical needs, and that applying consistent criteria – even in distressing individual cases – helps keep coverage sustainable and premiums affordable for the wider pool of policyholders. They would point out that an initial denial is not the end of the process: appeals exist so that new clinical evidence can be reviewed, and that treating physicians and insurance medical reviewers can reasonably disagree in good faith about whether a patient's current presentation meets the threshold for intensive inpatient rehabilitation as opposed to another appropriate level of care.
The case against
Trina Alvarez and those who share her view would argue that decisions of this magnitude are best made by the physicians who have examined the patient directly, rather than by insurance administrators applying general criteria at a remove, especially when a recognised specialist centre with a strong record of patient improvement has been recommended. They would contend that delaying access to intensive early rehabilitation after a severe brain injury risks squandering a critical recovery window, and that against a backdrop of public distrust in how insurers weigh cost against care, families are entitled to ask whether such denials properly account for the patient's best interests rather than the company's financial ones.